Article -> Article Details
| Title | Sleeping Bruxism Treatment Market Synopsis, Surge, Future Scope, Analysis and Forecast to 2030 |
|---|---|
| Category | Fitness Health --> Health Articles |
| Meta Keywords | Sleeping Bruxism Treatment Market, Sleeping Bruxism Treatment Market Size, Sleeping Bruxism Treatment Market Industry, Sleeping Bruxism Treatment Market Research, |
| Owner | Vaibhav |
| Description | |
| Sleeping Bruxism Treatment Market Sleep bruxism, which leads to
grinding teeth at night, is a condition that can result in disturbed sleep, is
an increasingly common condition. Reports that assess the healthcare industry
have been presented by Market Research Future, which creates reports on
numerous industry verticals that examine the market progress and forecasts. Sleeping Bruxism Treatment Market size is projected to be
worth USD 934.90 million by 2030, registering a CAGR of 5.95% during the
forecast period The rising pediatric population and
altering lifestyles are expected to motivate the sleeping bruxism treatment
market globally. The increased accessibility to therapeutic medicines is
projected to create an increased impetus for growth in the coming years. The
enhanced quality in preventive measures for treating sleeping bruxism is
expected to enhance the potential for growth in the approaching period. Major Key
Players: The Sleeping Bruxism Treatment Market Players are Pfizer Inc. (U.S.), Ipsen Biopharmaceuticals, Inc.
(U.S.), Henry Schein, Inc. (U.S.), Carestream Dental (U.S.), PLANMECA OY
(Finland), Akervall Technologies Inc. (U.S.), Merz Pharma GmbH & Co. KGaA
(Germany), Randmark Dental Products, LLC (U.S.), S4S Dental Laboratory (U.K.),
Patterson Dental Supply, Inc. (U.S.), Ivoclar Vivadent AG (Liechtenstein), and
others. Segment Analysis MRFR’s market study with
regard to sleeping bruxism treatment covers segments like type, diagnosis,
treatment type, cause, patient type, and end-user. The main types considered
in the market report include primary as well as secondary. The largest market
in 2017 belonged to secondary bruxism, as a result of the surge in sleep
disorders, rising intake of medicines that cause dental issues and evolving
lifestyles in light of growing stress. Treatment-wise, the key
market categories can be dental approaches as well as medication. The dental
approaches-based segments in the market are NTI-tss device and mouth guard. The
medication-wise categories include Botox injections, anti-anxiety drugs and
muscle relaxants. The key causes of sleeping
bruxism identified in the market study include sleep paralysis, obstructive
sleep apnea, malocclusion, gastroesophageal reflux disease (GERD), and more.
Between these, the obstructive sleep apnea category can touch USD 233.20
million by 2023, and also achieve an expansion rate of 7.0% during the given
period. Pediatric and adult remain
the two patient type segments in the market. In the year 2017, the pediatric
segment took the lead, as hyperactivity has become quite prevalent among
children, in addition to anger issues, rising pain from teething and earache,
and stress. Some of the prominent
end-users in the worldwide industry are dental clinics, hospitals, and others. Regional
Analysis The Americas, the Middle East and Africa/MEA, Asia Pacific/APAC and
Europe are the top markets for sleeping bruxism treatment. The Americas, in 2017, measured up to a share of 39.1% in the sleeping
bruxism treatment market. The key growth promoters include the escalating
anxiety and stress among people and the significant surge in government
spending on the target field. Mounting healthcare insurance among people also
contributes to the expansion of the regional market. A few other factors
encouraging market growth can be the rising introduction of innovative and
advanced devices, and the burgeoning geriatric population in the region,
especially in the United States, Mexico and Canada. Europe has procured the second position in the global market, due to the
apparent surge in sleeping bruxism cases among children and adults alike.
Strong economy, expanding dental awareness and high number of dental clinics
aid significantly in the market growth in Europe. An expanding pool of patients
suffering from snoring, irregular breathing and sleep disorders has also given
a boost to sleeping bruxism, marking substantial market progress in the region. With a steady advancement rate, the APAC market is largely backed by the
rapid increase in the use of quality healthcare technology, fast economic
growth and the massive population. Increasing spending on healthcare and the
considerable expansion of the pediatric population also serves as catalysts in
the market growth here. The growing knowledge level among people about sleep
bruxism and the thriving dental industry in India, Japan, South Korea and China
also bolster the market demand in APAC. About Market Research
Future At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end
users, and market players for global, regional, and country level market
segments, enable our clients to see more, know more, and do more, which help to
answer all their most important questions. In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members. Contact us: Market Research Future
(part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 646 845 9312 | |